Retro Biosciences
StartupUS1 field
Where it works
| Technology | ||
|---|---|---|
| Longevity biotechDevelops autophagy drugs, iPSC-derived cell therapies and tissue reprogramming aimed at adding ten healthy years. | Develops autophagy drugs, iPSC-derived cell therapies and tissue reprogramming aimed at adding ten healthy years. | retro.bio |
Funding
| Date | Round | Amount | |
|---|---|---|---|
| May 22, 2026 | Initial closeLed by 4P Capital | Amount not disclosed; $1.8B pre-money valuation | retro.bio |
About
- Source
- retro.bio (official, added by seed)
- First seen
- Sep 25, 2026
- Last seen
- Sep 25, 2026
| Date | Change | ||
|---|---|---|---|
| Sep 25, 2026 | Retro BiosciencesCompany in Longevity biotech: Joined a field, Develops autophagy drugs, iPSC-derived cell therapies and tissue reprogramming aimed at adding ten healthy years. | seed | retro.bio |
| Sep 25, 2026 | Retro BiosciencesCompany: Added | seed | retro.bio |